Company Filing History:
Years Active: 2003
Title: Lee Mark Wetzler: Innovator in Vaccine Development
Introduction
Lee Mark Wetzler is a prominent inventor based in New York, NY (US). He is known for his significant contributions to the field of vaccine development, particularly in relation to Neisseria. His innovative work has led to advancements that may enhance vaccine efficacy and safety.
Latest Patents
Wetzler holds a patent for a Neisserial vaccine that is free of immunologically functional PIII or class 4 proteins. This invention pertains to mutants of Neisseria that are useful for vaccine preparation. Specifically, it involves mutants of Neisseria that contain mutations in a major outer membrane protein gene, ensuring that no immunologically functional polypeptides encoded by that gene are produced. More precisely, the invention relates to a mutant strain with a mutation of the PIII gene and to vaccines derived from this strain.
Career Highlights
Wetzler is affiliated with The Rockefeller University, where he has been instrumental in advancing research in immunology and vaccine development. His work has garnered attention for its potential impact on public health and disease prevention.
Collaborations
Throughout his career, Wetzler has collaborated with notable colleagues, including Emil Claus Gotschlich and Milan S. Blake. These partnerships have contributed to the success of his research and the development of innovative solutions in the field.
Conclusion
Lee Mark Wetzler's contributions to vaccine development exemplify the importance of innovation in addressing public health challenges. His work continues to pave the way for future advancements in immunology and vaccine research.